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Oxidative stress plays a pathological role in the development of various diseases
including diabetes, atherosclerosis, or cancer. Systemic oxidative stress results
from an imbalance between oxidants derivatives production and antioxidants
defenses. Reactive oxygen species (ROS) are generally considered to be detrimental
for health. However, evidences have been provided that they can act as second
messengers in adaptative responses to stress. Obesity represents a major risk factor
for deleterious associated pathologies such as type 2 diabetes, liver, and coronary
heart diseases. Many evidences regarding obesity-induced oxidative stress
accumulated over the past few years based on established correlations of
biomarkers or end-products of free-radical-mediated oxidative stress with body
mass index. The hypothesis that oxidative stress plays a significant role in the
development of metabolic disorders, especially insulin-resistance state, is supported
by several studies where treatments reducing ROS production reverse metabolic
alterations, notably through improvement of insulin sensitivity, hyperlipidemia, or
hepatic steatosis. In this review, we will develop the mechanistic links between
oxidative stress generated by adipose tissue in the context of obesity and its impact
on metabolic complications development. We will also attempt to discuss potential
therapeutic approaches targeting obesity-associated oxidative stress in order to
prevent associated-metabolic complications.
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